SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of November, 2013

 

Prana Biotechnology Limited

(Name of Registrant)

 

Level 2, 369 Royal Parade Parkville  Victoria  3052 Australia

(Address of Principal Executive Office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F x Form 40-F ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):____

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):____

 

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes ¨ No x

 

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ____

 

 

 

 

 

 
 

 

PRANA BIOTECHNOLOGY LIMITED

 

6-K Items

 

1. Results of Annual General Meeting

  

 
 

 

 

 

 

PRANA BIOTECHNOLOGY LIMITED

(ASX: PBT)

 

RESULTS OF ANNUAL GENERAL MEETING

 

Thursday, 28th November 2013

 

The Company wishes to advise that all resolutions contained in the Notice of Meeting were carried on a show of hands.

 

In accordance with Listing rule 3.13.2 and Section 251AA(1) of the Corporations Act 2001, the following information is provided in relation to the resolutions considered by Members of the Company at the Annual General Meeting held today.

 

                      Total Valid 
                  Proxy's   Proxies 
   Resolutions   For    Against    Abstain   Discretion*   Received 
                        
1  Non-binding Resolution - Remuneration Report   60,771,272    3,667,139    24,431,402    6,799,030    95,668,843 
                             
2  Re-Election of Non-Executive Director - Mr Brian Meltzer   66,278,747    961,039    4,931,510    23,496,347    95,667,643 
                             
3  Ratification of previously issued securities - ATM   66,941,977    2,493,659    2,735,660    23,496,347    95,667,643 
                             
4  Approval of 10% Placement Issue   62,957,741    6,570,599    2,642,956    23,496,347    95,667,643 

 

* The Chairman voted undirected proxies in his control in favour of all resolutions.

 

On behalf of the Board

 

/s/ Richard Revelins

Richard Revelins

Company Secretary

Prana Biotechnology Limited

 

Suite 2, 1233 High Street Armadale

Victoria Australia 3143 

 Page 1 of 1

Telephone: 61 3 9824 8166

Facsimile: 61 3 9824 8161 

  

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  PRANA BIOTECHNOLOGY LIMITED
  (Registrant)
     
  By  /s/ Geoffrey Kempler
    Geoffrey Kempler,
    Executive Chairman

 

November 27, 2013